The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global implantable medical devices market was valued at US$ 120.5 Billion in 2021.
We expect the global implantable medical devices market to exhibit a CAGR of 5.54% during 2022-
The high prevalence of numerous chronic diseases, such as cardiac arrest, arthritis, sensory or
cognitive modality, etc., particularly among geriatric population, is currently driving the global
implantable medical devices market.
The sudden outbreak of the COVID-19 pandemic had led to the decline in hospital visits and
postponement of several elective surgical procedures to mitigate the risk of COVID-19 transmission,
thereby negatively impacting the demand for implantable medical devices.
Based on the product type, the global implantable medical devices market can be divided into
orthopedic implants, dental implants, facial implants, breast implants, cardiovascular implants, and
others. Among these, orthopedic implants hold the majority of the total market share.
Based on the material, the global implantable medical devices market has been bifurcated into
polymers, metals, ceramics, and biologics. Currently, polymer-based implantable devices exhibit a
clear dominance in the market.
Based on the end-user, the global implantable medical devices market can be segmented into
hospitals, Ambulatory Surgery Centers (ASCs), and clinics. Among these, hospitals account for the
largest market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global implantable medical devices market include Abbott
Laboratories, Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Conmed
Corporation, Globus Medical, Inc., Integra Lifesciences Holdings Corporation, Johnson & Johnson,
LivaNova PLC, Medtronic plc, Nuvasive, Inc., Smith & Nephew Plc, St. Jude Medical, Inc., Institut
Straumann AG., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at